Drug Type Small molecule drug |
Synonyms PANTEC TIME, 판텍타임건조시럽 |
Action inhibitors, antagonists, agonists, + [1] |
Mechanism COX inhibitors(Cyclooxygenases inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists), NMDA receptor antagonists(Glutamate [NMDA] receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (31 Jul 2025), |
Regulation- |
Molecular FormulaC17H20N4O6 |
InChIKeyAUNGANRZJHBGPY-SCRDCRAPSA-N |
CAS Registry83-88-5 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Common Cold | South Korea | 31 Jul 2025 |